EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Liraglutide Pretreatment Does Not Improve Acute Doxorubicin-Induced Cardiotoxicity in Rats

Carolina R Tonon iD, Marina G Monte iD, Paola S Balin iD, Anderson S S Fujimori, Ana Paula D Ribeiro, Natália F Ferreira, Nayane M Vieira, Ronny P Cabral, Marina P Okoshi iD, Katashi Okoshi iD, Leonardo A M Zornoff, Marcos F Minicucci und 3 weitere

International Journal of Molecular Sciences · 2024

DOI: 10.3390/ijms25115833 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Carolina R Tonon und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Botucatu Medical School, São Paulo State University (UNESP), Botucatu 18618-687, SP, Brazil. Hauptthemen laut MEDLINE: Liraglutide, Doxorubicin, Cardiotoxicity, Rats, Wistar. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 116 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fundação de Amparo à Pesquisa do Estado de São Paulo, Conselho Nacional de Desenvolvimento Científico e Tecnológico.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Doxorubicin is an effective drug for cancer treatment; however, cardiotoxicity limits its use. Cardiotoxicity pathophysiology is multifactorial. GLP-1 analogues have been shown to reduce oxidative stress and inflammation. In this study, we evaluated the effect of pretreatment with liraglutide on doxorubicin-induced acute cardiotoxicity. A total of 60 male Wistar rats were allocated into four groups: Control (C), Doxorubicin (D), Liraglutide (L), and Doxorubicin + Liraglutide (DL). L and DL received subcutaneous injection of liraglutide 0.6 mg/kg daily, while C and D received saline for 2 weeks. Afterwards, D and DL received a single intraperitoneal injection of doxorubicin 20 mg/kg; C and L received an injection of saline. Forty-eight hours after doxorubicin administration, the rats were subjected to echocardiogram, isolated heart functional study, and euthanasia. Liraglutide-treated rats ingested significantly less food and gained less body weight than animals that did not receive the drug. Rats lost weight after doxorubicin injection. At echocardiogram and isolated heart study, doxorubicin-treated rats had systolic and diastolic function impairment. Myocardial catalase activity was statistically higher in doxorubicin-treated rats. Myocardial protein expression of tumor necrosis factor alpha (TNF-α), phosphorylated nuclear factor-κB (p-NFκB), troponin T, and B-cell lymphoma 2 (Bcl-2) was significantly lower, and the total NFκB/p-NFκB ratio and TLR-4 higher in doxorubicin-treated rats. Myocardial expression of OPA-1, MFN-2, DRP-1, and topoisomerase 2β did not differ between groups (p > 0.05). In conclusion, doxorubicin-induced cardiotoxicity is accompanied by decreased Bcl-2 and phosphorylated NFκB and increased catalase activity and TLR-4 expression. Liraglutide failed to improve acute doxorubicin-induced cardiotoxicity in rats.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

LiraglutideDoxorubicinCardiotoxicityRats, WistarAnimalsMaleRatsOxidative StressMyocardiumNF-kappa BTumor Necrosis Factor-alphaHeart

Stichwörter der Autor:innen

acute cardiotoxicitydoxorubicinheart failure

Substanzen

LiraglutideDoxorubicinNF-kappa BTumor Necrosis Factor-alpha

Autor:innen und Institutionen

  • Department of Internal Medicine, Botucatu Medical School, São Paulo State University (UNESP), Botucatu 18618-687, SP, Brazil.
  • Department of Kinesiology and Sport Management, Texas A&M University, College Station, TX 77843, USA.

ORCID-Profile: Carolina R Tonon, Marina G Monte, Paola S Balin, Marina P Okoshi, Katashi Okoshi, Mariana J Gomes, Bertha F Polegato

Förderung

  • Fundação de Amparo à Pesquisa do Estado de São Paulo
  • Conselho Nacional de Desenvolvimento Científico e Tecnológico

Zitieren

APA

Tonon, C. R., Monte, M. G., Balin, P. S., Fujimori, A. S. S., Ribeiro, A. P. D., Ferreira, N. F., Vieira, N. M., Cabral, R. P., Okoshi, M. P., Okoshi, K., Zornoff, L. A. M., Minicucci, M. F., Paiva, S. A. R., Gomes, M. J., & Polegato, B. F. (2024). Liraglutide Pretreatment Does Not Improve Acute Doxorubicin-Induced Cardiotoxicity in Rats. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25115833

Vancouver

Tonon CR, Monte MG, Balin PS, Fujimori ASS, Ribeiro APD, Ferreira NF, et al. Liraglutide Pretreatment Does Not Improve Acute Doxorubicin-Induced Cardiotoxicity in Rats. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms25115833

BibTeX
@article{Tonon2024,
  author = {Tonon, Carolina R and Monte, Marina G and Balin, Paola S and Fujimori, Anderson S S and Ribeiro, Ana Paula D and Ferreira, Natália F and Vieira, Nayane M and Cabral, Ronny P and Okoshi, Marina P and Okoshi, Katashi and Zornoff, Leonardo A M and Minicucci, Marcos F and Paiva, Sergio A R and Gomes, Mariana J and Polegato, Bertha F},
  title = {Liraglutide Pretreatment Does Not Improve Acute Doxorubicin-Induced Cardiotoxicity in Rats},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  doi = {10.3390/ijms25115833}
}
Kostenlos starten →